Conformational perturbation of the envelope glycoprotein gp120 of human immunodeficiency virus type 1 by soluble CD4 and the lectin succinyl Con A.
We have studied perturbation of the gp120/gp41 envelope complex of HIV-1 in the presence of the mannose-specific lectin succinyl Con A (SC) and compared the effect with that observed in the presence of soluble CD4 (sCD4). SC did not inhibit the binding of gp120 to CD4. Both sCD4 and SC inhibited syncytium formation induced by HIV-1-infected Molt3/HIV-1IIIB cells. The infectivity of HIV-1 was markedly reduced when the virions were preincubated with SC or when SC was mixed simultaneously with virus and cells. The conformation of gp120 was altered in the presence of SC as evidenced by an increased susceptibility of the principal neutralizing epitope (V3 loop) to thrombin digestion. SC treatment of [35S]-methionine-labeled virions derived from Molt3/HIV-1IIIB cells resulted in the dissociation of gp120 from the viral membrane. The effect was less pronounced than that observed with sCD4. These results suggest that although interacting with different regions of gp120, the mannose-specific lectin alters the conformation of the glycoprotein in a manner similar to that induced by sCD4, causing destabilization of the gp120/gp41 complex.
Advanced BioScience Laboratories, Incorporated, Department of Cell Biology, Kensington, Maryland 20895.
R
R
Pal
A
A
DeVico
S
S
Rittenhouse
M G
MG
Sarngadharan
D015704:CD4 Antigens / Q000494:pharmacology*; D002459:Cell Fusion / Q000187:drug effects; D003208:Concanavalin A / Q000494:pharmacology*; D015699:HIV Envelope Protein gp120 / Q000187:drug effects / Q000378:metabolism*; D015497:HIV-1 / Q000378:metabolism*; D011487:Protein Conformation / Q000187:drug effects; D012995:Solubility
D015704:CD4 Antigens; D015699:HIV Envelope Protein gp120; D003208:Concanavalin A; C019558:succinylconcanavalin A